UNM Newsroom | DNA editing revolution : Bayer will invest 325 million euros to CRISPR Therapeutics – Albuquerque Tech Time Daily Star Gazette Bayer will spend 325 million euros ($353 million) on research into a promising new gene editing technology as part of a joint venture with biotech firm CRISPR Therapeutics.Under the deal, the German drugmaker will pay for the joint venture's research ... UNM undergrads among first to train using new genome editing technology |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]-revolution-bayer-will-invest-